University of Missouri launches first on-campus radiopharmaceutical clinical trial
In a major leap for cancer care at the University of Missouri, the School of Medicine and MU…
Novel neuroprotective drug improves recovery after acute ischemic stroke
Stroke patients treated intravenously with loberamisal, a novel neuroprotective medication, daily for 10 days and starting within 48…
Stem cell implants aim to restore dopamine in Parkinson’s disease
Parkinson’s disease is a progressive neurodegenerative disorder that affects more than one million people in the United States,…
Treating desmoplastic melanoma with immunotherapy before surgery can shrink or eliminate tumors
New results from a clinical trial co-led by UCLA investigators demonstrate how treating desmoplastic melanoma, a rare and…
Eating beef as part of a healthy dietary pattern does not impact risk factors for type 2 diabetes
More than 135 million American adults are either living with or at risk for type 2 diabetes (T2D),…
New trial tests strategies to protect heart health during prostate cancer therapy
City of Hope®, one of the largest and most advanced cancer research and treatment organizations in the United States…
Regular aerobic exercise slows a key marker of brain aging in midlife
A year of consistent aerobic activity didn’t just boost fitness; it shifted MRI-based brain age in early to…
AskBio Announces FDA Acceptance of Investigational New Drug (IND) Application for AB-1009 Gene Therapy for Treatment of Late-Onset Pompe Disease (LOPD)
Durham, N.C., Jan. 08, 2026 (GLOBE NEWSWIRE) — AB-1009 program advances to Phase 1/Phase 2; clinical trial initiated…
Restoring brain energy balance reverses Alzheimer’s disease in mouse models
For over a century, Alzheimer’s disease (AD) has been considered irreversible. Consequently, research has focused on disease prevention…
Women may derive greater long-term benefits from coronary artery bypass grafting compared with stents
Women with severe coronary heart disease causing narrowing or blockages in the arteries may derive greater long-term benefits…
Lilly’s triple agonist, retatrutide, delivered weight loss of up to an average of 71.2 lbs along with substantial relief from osteoarthritis pain in first successful Phase 3 trial
In TRIUMPH-4, participants with obesity and knee osteoarthritis taking retatrutide 12 mg lost an average of 28.7% of…
UC Irvine receives funding for clinical trial of neural stem cell therapy for Huntington’s disease
Leslie M. Thompson, Donald Bren Professor of psychiatry and human behavior as well as neurobiology and behavior at…